HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business (Cosmetics)

Deals

Set Alert for Deals (Beauty)

Latest From Beauty & Deals

Perfect Corp. Highlights Results Of AR-Based Nail Color Sampling At Sally Hansen

Sally Hansen has seen a 300% increase in shades viewed on its website, and a 120% increase in intent to buy, since it introduced Perfect Corp.’s AR-based virtual try-on tool, the beauty tech firm says. French nail-color specialist Manicurist is the latest to partner with Perfect for its Green Flash brand.

Advertising, Marketing & Sales Deals

J&J Has Kenvue IPO Roadshow In One Lane, Potentially Long Road For Talc Litigation In Other

Roadshow stated for IPO planned for before end of 2023 of 151.2m shares of Kenvue common stock currently expected at between $20 and $23 per share. Analysts positive on IPO but caution launch wouldn’t come problem-free.

Consumer Legal Issues

Bayer Trims Consumer Portfolio Selling Solarcaine, Other US, Canada Skin Care Brands To WellSpring

WellSpring, owned by private equity firm Avista Capital Partners, purchasing Solarcaine, diaper rash and skin protectant A+D and Canadian brands Cortate and Complex 15. Bayer’s long-term commitment to consumer health one of key issues facing its next CEO, Bill Anderson.

Deals OTC Drugs
See All

Strategy

Set Alert for Strategy (Beauty)

Latest From Beauty & Business Strategies

Homeopathics, Supplements, OTC Medicines Overlap In Pharmacists’ ‘Over-The-Counter’ Survey

Results of U.S. News & World Report’s first “Best OTC Medicine & Health Products” survey include homeopathic formulations, supplements and non-drug topicals in same categories of indications with nonprescription pharmaceuticals.

Consumer Market Intelligence

Perfect Corp. Highlights Results Of AR-Based Nail Color Sampling At Sally Hansen

Sally Hansen has seen a 300% increase in shades viewed on its website, and a 120% increase in intent to buy, since it introduced Perfect Corp.’s AR-based virtual try-on tool, the beauty tech firm says. French nail-color specialist Manicurist is the latest to partner with Perfect for its Green Flash brand.

Advertising, Marketing & Sales Deals

Amyris Moving 30 Molecules Through R&D Pipeline, Streamlining Consumer Portfolio

Amyris, Inc. is developing 30 molecules using its bio-fermentation technology, negotiating a bio-manufacturing joint venture that could yield $50m-$100m in proceeds, and simplifying its Consumer portfolio to unlock value. Cost containment and liquidity will continue to be key priorities for the synthetic biotech firm while it targets up to 100% revenue growth in fiscal 2023.

Sales & Earnings Commercial
See All

Sales & Earnings

Set Alert for Sales & Earnings (Beauty)

Latest From Beauty & Sales & Earnings

Amyris Moving 30 Molecules Through R&D Pipeline, Streamlining Consumer Portfolio

Amyris, Inc. is developing 30 molecules using its bio-fermentation technology, negotiating a bio-manufacturing joint venture that could yield $50m-$100m in proceeds, and simplifying its Consumer portfolio to unlock value. Cost containment and liquidity will continue to be key priorities for the synthetic biotech firm while it targets up to 100% revenue growth in fiscal 2023.

Sales & Earnings Commercial

Coty Touts ‘Huge Potential’ In China With Lancaster Skin Care, Rising Fragrance Opportunity

New York-based beauty giant says its strategic bet on skin care in China is starting to pay off with strong consumer response to the recent launch of Lancaster Ligne Princiere. Meanwhile, the firm is ready to deploy its prestige fragrance brands strategically in the country as consumers gravitate increasingly to high-end perfumes.

Business Strategies Sales & Earnings

Estee Lauder Companies’ Post-Pandemic Struggle Continues In Q3; Travel Retail Down 45%

Lauder lowers its fiscal 2023 full-year sales guidance a third time as travel retail recovery in Asia lags and global travel retail sales plunge 45% organically. On the bright side, the rest of the firm’s business grew 10%.

Commercial Sales & Earnings
See All
UsernamePublicRestriction

Register